Delivering Team-Based Preventive Health Maintenance in IBD: Wrap-Around Interdisciplinary Care


Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair of Medicine
Department of Internal Medicine
University of Cincinnati College of Medicine
Associate Chief Medical Officer
UC Health System
Cincinnati, OH
Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Anita Afzali, MD, MPH, MHCM, is a Professor of Clinical Medicine and a gastroenterologist that specializes in Inflammatory Bowel Disease (IBD). She has recently transitioned to the University of Cincinnati after successfully building the first standalone multidisciplinary IBD Center and serving as the Medical Director at The Ohio State University Wexner Medical Center for five years. Dr. Afzali is now the Executive Vice Chair of the Department of Internal Medicine at the University of Cincinnati and Associate Chief Medical Officer of UC Health Systems and Cincinnati Children’s Hospital. She received her medical degree and completed both an Internal Medicine residency and Gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology and graduated with a Master’s in Public Health. She recently obtained an additional Master’s in Health Care Management for physician executive leadership and business administration from Harvard University. Her areas of research interest include clinical outcomes and clinical trials for investigative therapies and diagnostics in IBD. She is a healthcare redesign leader with interests in clinical operations and transformative medical care delivery. Dr. Afzali has extensive peer-reviewed publications and is a clinical trialist in over 20 investigative drug and diagnostic trials. She is also an invited lecturer on national and international programs and serves on several international advisory boards and scientific committees. Dr. Afzali is the incoming Chair of the American College of Gastroenterology (ACG) Educational Affairs Committee and the incoming Chair of the World Gastroenterology Organization (WGO) Publications Committee, as well as Co-Editor of the WGO quarterly global newsletters.

Statement of Need

Studies have shown that patients with inflammatory bowel disease (IBD) are less likely than patients without IBD to receive needed preventive health maintenance. Effective preventive measures are critical in reducing morbidity, hospitalization, and surgery as well as improving disease-free remission and quality of life in patients with IBD. It is key for clinicians working in both primary care and gastroenterology settings to understand the preventive health maintenance needs of their patients with IBD. Clinicians should tailor their approach based on patient age as preventive health guidelines and vaccination guidelines are age specific. As 25% of patients with IBD are diagnosed before age 20, it is critical that providers be aware of screening recommendations specific to the pediatric patient population.

After completion of this Adaptive Learning OnDemand activity developed by Dr. Anita Afzali, learners will be able to manage and maintain patient vaccinations, perform appropriate and regular screenings for cancer and depression/anxiety, and effectively provide age-specific preventive care for patients with IBD by using current guidelines and a team-based approach.

Learning Objectives

  • Integrate recommended vaccinations into gastroenterology clinical practice to improve health outcomes for patients with IBD, especially older adults.
  • Develop a health screening plan for patients with IBD, including cancer, bone health, and depression/anxiety screenings.
  • Implement a team-based approach to preventive care management for pediatric patients with IBD.

Financial Support

Supported by an educational grant from Pfizer Inc.

Target Audience

Community gastroenterologists, physician associates (PAs), nurse practitioners (NPs), pharmacists, primary care physicians, and pediatricians

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-150-H01-P

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Afzali reports the following financial relationships:

Consultant: Abbvie Inc.; Arena Pharmaceuticals, Inc.; Bristol Myers Squibb; DiaSorin Molecular LLC; Eli Lilly and Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals; Pfizer Inc.; Takeda Pharmaceutical Company; and TLL Pharmaceuticals

Grants: AbbVie Inc.; Bristol Myers Squibb; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceutical Company.

Other financial or material support: Co-Founder, Board Member of IBD Horizons.
Co-Founder, Board Member; Scrubs & Heels, LLC.

The following peer reviewer and CME Outfitters staff have no financial relationships:

  • Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)
  • Susan Perry (planning committee)
  • Kasey Brandt, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.



Delivering Team-Based Preventive Health Maintenance in IBD: Wrap-Around Interdisciplinary Care
Event Date: 12/29/2022